Pharmaceutical

Chime Biologics, Leads and Beigene enter antibody development deal

Chime Biologics, Leads Biolabs and BeiGene have entered a strategic partnership to expedite the development of a monoclonal antibody, LBL-007.

Jul 3, 2023 - 20:00
Chime Biologics, Leads and Beigene enter antibody development deal
Chime Biologics, Leads Biolabs and BeiGene have entered a strategic partnership to expedite the development of a monoclonal antibody, LBL-007.
Read the original article

Tags:

Previous Article

Madrigal seeks expedited approval for NASH treatment

Next Article

Knowledge powerhouses urged to join pioneering Africa-led mission to level up gl...

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Could preventative care save the future of the NHS?

Could preventative care save the future of the NHS?

Oct 10, 2024

Opinion: The pink ribbon of breast cancer awareness needs a splash of blue for men

Opinion: The pink ribbon of breast cancer awareness nee...

Oct 28, 2023

STAT+: Goldman Sachs launches $650 million fund for life sciences investments

STAT+: Goldman Sachs launches $650 million fund for lif...

Jan 4, 2024